People
Contact

Services
Investors
International Associates
In-house IP departments

Patents
Drafting new applications
Filing applications and taking them to grant
EPO opposition
Restorations
Freedom to operate
Patent landscaping
Patent Box
The Unitary Patent and the Unified Patent Court (UPC)
Supplementary protection certificates (SPC)

Trade marks
Why choose us to protect your brands
Filing and prosecution
Opposition
Enforcement
Clearance and freedom to use
Trade mark watches
Domain names

Designs
Guide to registered designs
Registered rights
Unregistered rights

Copyright
Copyright - overview

Intellectual Property Strategy
IP audits
Due diligence
Portfolio management
Transactions

Sectors
Aerospace
Automotive
Battery technology
Creative industries
Defence and security
Electronics
Food and drink
Gaming
Healthcare
Software
Industrial chemistry
Internet and domain names
Life sciences and industrial biochemistry
Oil and gas
Pharmaceutical chemistry and biopharmaceuticals
Renewable Energy
Sports
Textiles

About us
History
Corporate Social Responsibility
Complaints

Resources
Guide to patents
Practical Guide to: European Patents and the Unitary Patent System (UPC)
Guide to registered designs
Guide to trade marks
Brexit - the Impact on Intellectual Property

News
News
Insights
Events

Careers
Vacancies
Our culture

Day in the life
Day in the life of a partner
Day in the life of an associate
Day in the life of a trainee
Day in the life of a support colleague

Services
Services
Sectors
Sectors
People
About us
About us
Resources
Resources
News
News
- News
- Insights
- Events
Careers
Careers
Contact

Search

Home
Resources
Newsletters
The EPO raises...

The EPO raises the bar on plausibility when assessing inventive step: T488/16 - Dasatinib

Posted on February 03, 2017

Share

Facebook
Twitter
LinkedIn
Mail

Download PDF version

Fill out the form and
we’ll be in touch.

Your name *

Your Email *

Telephone

Message

Or email us
any time

Existing customers
ai@abelimray.com

New customers
bd@abelimray.com

London: Abel + Imray; 20 St. Andrew Street; London; EC4A 3AG UK; t: +44 (0) 20 7242 9984; ai@abelimray.com; View map

Cardiff: Abel + Imray; 3 Assembly Square; Britannia Quay; Cardiff; CF10 4PL UK; t: +44 (0) 29 2089 4200; ai@abelimray.com; View map

Bath: Abel + Imray; Westpoint Building; James Street West; Bath; BA1 2DA UK; t: +44 (0) 1225 469 914; ai@abelimray.com; View map

Delft: Abel + Imray; Crommelinplein 1; 2627BM Delft; The Netherlands; t: +31 (0) 15 8080 194; ai@abelimray.nl; View map

Ribadeo: Abel + Imray; Avda. Rafael Fernández Cardoso; 20-22; Bajo 1; Local 7 27700 Ribadeo; (Lugo); Spain; t: +34 982 480 332; ai@abelimray.com; View map

Terms Privacy and Cookies Policies

© 2024 Abel & Imray LLP
Abel + Imray is a trading name of Abel & Imray LLP. Abel & Imray LLP is a Limited Liability Partnership (number OC438716) registered in England and Wales, whose registered office address is 20 St. Andrew Street, London, UK, EC4A 3AG. Regulated by IPReg . Partners are UK registered patent and/or trade mark attorneys.